FDA approved a once-daily Zilbrysq autoinjector for generalized myasthenia gravis. It launches in early 2027 with the same meningococcal infection warning.
Zilbrysq Autoinjector Wins FDA Approval for Generalized Myasthenia Gravis, but Patients Must Wait Until Early 2027
by | Oct 20, 2026 | Uncategorized | 0 comments
Recent Comments